FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to traumatology. Bone fracture is simulated in rats. Then the Neovasculgen preparation in a single dose of 120 mcg is injected intramuscularly into the area of surgical intervention twice: the first dose in 1 hour after operation, the second dose in 24 hours after operation.
EFFECT: method enables improving the quality of life of the patients with bone fractures due to faster and more qualitative bone tissue recovery.
1 cl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF CHANGING OSSEOUS TISSUE STRUCTURE IN EXPERIMENTAL STEROID OSTEOPOROSIS SIMULATION | 2008 |
|
RU2371189C1 |
METHOD OF PREPARING FILLING MASS FOR CLOSURE OF BONE DEFECT | 2017 |
|
RU2676478C1 |
METHOD OF BONE DEFECT CLOSURE | 2017 |
|
RU2644828C1 |
METHOD FOR SIMULATING TRAUMATIC OSTEOMYELITIS | 2015 |
|
RU2584402C1 |
METHOD FOR SIMULATING OSTEORESORPTION UNDER OSTEOGENESIS CONDITIONS | 2013 |
|
RU2524128C1 |
METHOD OF STIMULATING REPARATIVE OSTEOGENESIS | 2010 |
|
RU2429002C1 |
AGENT FOR GROWTH STIMULATION OF GRANULOCYTE AND LYMPHOID CELLS IN BONE MARROW AND REGENERATION OF BONE TISSUE AND METHOD OF ITS PRODUCTION | 2017 |
|
RU2673537C2 |
METHOD FOR PHARMACOLOGICAL CORRECTION OF OXIDATIVE DISORDERS ACCOMPANYING OSTEOPOROSIS IN EXPERIMENT WITH CHONDROITIN SULPHATE | 2024 |
|
RU2832054C1 |
AGENT FOR STIMULATION OF REPARATIVE OSTEOGENESIS | 2015 |
|
RU2606257C1 |
METHOD OF TREATING PATIENTS WITH BONE FRACTURES | 2010 |
|
RU2427398C1 |
Authors
Dates
2025-04-28—Published
2023-12-28—Filed